News about Global Pharma

Asahi Kasei Introduces Membrane System to Produce Water for Injection

Asahi Kasei has begun selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injections.

Global Pharma | 13/06/2024 | By Aishwarya |  546

Lupin Signs License and Supply Deal with Fuji for Commercialization of Nextstellis

Lupin has signed a license and supply agreement with OLIC (Thailand) LTD. (OLIC), a subsidiary of the renowned Japanese pharmaceutical company Fuji Pharma Co., Ltd. (Fuji), for marketing Nextstellis (drospirenone and estetrol tablets) in Vietnam and Philippines.

Global Pharma | 13/06/2024 | By Aishwarya |  1896

Charles River Laboratories, MatTek Receive Grant from FCRI to Advance Research Alternatives

Charles River Laboratories International, Inc. has announced a multidisciplinary program, funded through a USD 1.3 million grant from the Foundation for Chemistry Research & Initiatives (FCRI), in coordination with ACC LRI, to develop a New Approach Methodology (NAM) inhalation toxicology test to reduce reliance on traditional animal research methods.

Global Pharma | 12/06/2024 | By Aishwarya |  830

FDA Grants IND Approval for Lomonitinib to Eilean Therapeutics

Eilean Therapeutics has announced that the US Food and Drug Administration (FDA) has cleared the IND for lomonitinib (ZE46-0134).

Global Pharma | 11/06/2024 | By Aishwarya |  550

Gland Pharma Appoints New Executive Chairman and CEO

Gland Pharma Ltd. has announced that Srinivas Sadu has been appointed as Executive Chairman and CEO of the company.

Global Pharma | 11/06/2024 | By Aishwarya |  1189

Calyx / Invicro Partners with BAMF Health to Boost Clinical Translation of RLT and IO Agents

Calyx / Invicro has announced a strategic partnership with BAMF Health, a world leader in molecular imaging and theranostics.

Global Pharma | 10/06/2024 | By Aishwarya |  625

Schneider Electric Introduces EcoStruxure for Life Science Segment

Schneider Electric has released EcoStruxure, a next-generation software technology, for its Life Sciences Segment.

Global Pharma | 10/06/2024 | By Aishwarya |  1221

Lupin Acquires Two Brands from Sanofi in Europe and Canada

Lupin has announced that its European hub entity, Lupin Atlantis Holdings SA, has completed the acquisition of two well-known brands, Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights, from Sanofi.

Global Pharma | 10/06/2024 | By Aishwarya |  1656

Cycle Pharmaceuticals Offers All-Cash Proposal to Acquire Vanda Pharmaceuticals

Cycle Pharmaceuticals Ltd. has confirmed that it proposed to the Board of Directors of Vanda Pharmaceuticals, Inc. to acquire 100 percent of Vanda’s issued and outstanding shares for a cash consideration of USD 8.00 per Vanda share.

Global Pharma | 07/06/2024 | By Aishwarya |  1008

CordenPharma Announces Partnership with Certest

CordenPharma has signed a collaboration agreement with Certest, a Spanish company focused on the development of new products with special emphasis in Drug Delivery with LNPs and API synthesis.

Global Pharma | 07/06/2024 | By Aishwarya |  487